This inventor holds 11 USPTO granted patents, plus 1 CIPO patent and 2 EPO patents. Top assignee: Bristol-Myers Squibb Compnay. Active years: 2005-2010.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Location History:
- Hopewell, NJ (US) (2005 - 2009)
- Lawrenceville, NJ (US) (2009 - 2010)
Company Filing History:
Years Active: 2005-2010
Title: **Inventor Ligang Qian: Pioneering Anti-Cancer Innovations**
Introduction
Ligang Qian, an esteemed inventor based in Hopewell, NJ, has made significant contributions to the field of medicinal chemistry, particularly in developing innovative anti-cancer agents. With a remarkable portfolio of 11 patents, his work focuses on advancing treatments for various diseases by targeting key mechanisms in signal transduction pathways.
Latest Patents
Qian's latest groundbreaking patents include "Inhibitors of Kinases" and "Heterocyclic Inhibitors of Kinases". These inventions present compounds represented by formula I, which are characterized by their ability to inhibit the tyrosine kinase activity of growth factor receptors such as VEGFR-2 and FGFR-1. The implications of these compounds are profound, as they hold promise not only as anti-cancer agents but also as potential treatments for other diseases linked to disrupted signal transduction pathways.
Career Highlights
Ligang Qian's career is notably marked by his work at Bristol-Myers Squibb Company, a pharmaceutical giant renowned for its commitment to developing innovative therapies. His inventive contributions have played a critical role in the company's mission to address unmet medical needs through effective therapeutic solutions.
Collaborations
Throughout his career, Qian has collaborated with esteemed colleagues such as Rajeev S Bhide and Zhen-Wei Cai. These partnerships have enabled the cross-pollination of ideas and expertise, fostering an environment of innovation that has led to the successful development of novel compounds targeting cancer.
Conclusion
Ligang Qian exemplifies the spirit of innovation in the pharmaceutical industry. His dedication to research and development has resulted in valuable patents that contribute significantly to cancer treatment methodologies. As the field of medicinal chemistry continues to evolve, Qian's work stands as a testament to the impact of inventive research on global health.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile